Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TML-023 Ointment in Proliferative Superficial Infantile Hemangioma (Phase IIIb, Single-Arm)
CTR20255106Phase 3Active
- Sponsor
- Wuhan Kefu New Drug
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of timolol in Capillary Haemangioma, sponsored by Wuhan Kefu New Drug. Started Mar 2026; status: active.
02
Drugs
timolol
03
Conditions
Capillary Haemangioma
Beyond the preview
Go deeper on CTR20255106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20255106.